Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 37,930 | 39,467 | 38,505 | 38,442 | 30,185 |
| Cost of Goods | 14,356 | 14,189 | 10,765 | 9,991 | 6,222 |
| Gross Profit | 23,574 | 25,278 | 27,740 | 28,451 | 23,963 |
| Operating Expenses | 85,526 | 81,792 | 78,270 | 70,722 | 68,424 |
| Operating Income | -61,596 | -56,325 | -49,765 | -41,280 | -44,239 |
| Other Income | 239 | 327 | 464 | 638 | 785 |
| Pre-tax Income | -61,357 | -55,998 | -49,301 | -40,642 | -43,454 |
| Net Income Continuous | -61,357 | -55,998 | -49,301 | -40,642 | -44,570 |
| Minority Interests | 76 | -95 | N/A | N/A | N/A |
| Net Income | $-61,433 | $-55,903 | $-49,301 | $-40,642 | $-44,570 |
| EPS Basic Total Ops | -0.44 | -0.40 | -0.35 | -0.29 | -0.33 |
| EPS Basic Continuous Ops | -0.44 | -0.40 | -0.35 | -0.29 | -0.33 |
| EPS Diluted Total Ops | -0.44 | -0.40 | -0.35 | -0.29 | -0.33 |
| EPS Diluted Continuous Ops | -0.44 | -0.40 | -0.35 | -0.29 | -0.33 |
| EBITDA(a) | $-55,470 | $-51,015 | $-44,794 | $-36,501 | $-40,630 |